Cefepime 1 G Fresenius, Cefepime 2 G Fresenius 1 g, 2g Powder for solution for injection or infusion
PDF Leaflet Revision Date: 16 March 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by susceptible bacteria.
Dosage (summary)
Adults: 500 mg - 2 g IV/IM every 8-12 hours based on infection severity.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Aminoglycosides
- Warfarin
- Probenecid
Contraindications
- Hypersensitivity to cefepime
- History of cephalosporin allergy
Common side effects
- Diarrhoea
- Nausea
- Skin rash
- Hypersensitivity reactions
Counselling Points
- Monitor for allergic reactions
- Report severe gastrointestinal symptoms
- Avoid driving if experiencing dizziness or confusion
Serious warnings
- Severe hypersensitivity reactions
- Risk of Clostridium difficile-associated diarrhoea
- Neurotoxicity in renal impairment
Important Disclaimer
The Cefepime 1 G Fresenius, Cefepime 2 G Fresenius 1 g, 2g Powder for solution for injection or infusion professional information leaflet below is the property of Fresenius Kabi South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
